BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12039695)

  • 1. Expression of cAMP-responsive element binding protein and inducible cAMP early repressor in hyperfunctioning thyroid adenomas.
    Peri A; Luciani P; Tonacchera M; Agretti P; Baglioni-Peri S; Buci L; Conforti B; Cioppi F; Biliotti G; Serio M; Vitti P; Chiovato L
    Eur J Endocrinol; 2002 Jun; 146(6):759-66. PubMed ID: 12039695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gsalpha gene.
    Peri A; Conforti B; Baglioni-Peri S; Luciani P; Cioppi F; Buci L; Corbetta S; Ballaré E; Serio M; Spada A
    J Clin Endocrinol Metab; 2001 May; 86(5):2111-7. PubMed ID: 11344215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas.
    Brunetti A; Chiefari E; Filetti S; Russo D
    Endocrinology; 2000 Feb; 141(2):722-30. PubMed ID: 10650954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for cAMP-response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture.
    Uyttersprot N; Costagliola S; Dumont JE; Miot F
    Eur J Biochem; 1999 Jan; 259(1-2):370-8. PubMed ID: 9914516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R.
    Groussin L; Massias JF; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):345-54. PubMed ID: 10634409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours.
    Luciani P; Buci L; Conforti B; Tonacchera M; Agretti P; Elisei R; Vivaldi A; Cioppi F; Biliotti G; Manca G; Vitti P; Serio M; Peri A
    Eur J Endocrinol; 2003 May; 148(5):579-86. PubMed ID: 12720543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas.
    Peri A; Luciani P; Conforti B; Baglioni-Peri S; Cioppi F; Crescioli C; Ferruzzi P; Gelmini S; Arnaldi G; Nesi G; Serio M; Mantero F; Mannelli M
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5443-9. PubMed ID: 11701720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human endometrial stromal cells express novel isoforms of the transcriptional modulator CREM and up-regulate ICER in the course of decidualization.
    Gellersen B; Kempf R; Telgmann R
    Mol Endocrinol; 1997 Jan; 11(1):97-113. PubMed ID: 8994192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
    Holzapfel HP; Bergner B; Wonerow P; Paschke R
    Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
    Kamiya Y; Murakami M; Yanagita Y; Koitabashi H; Nagamachi Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):137-42. PubMed ID: 9685222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.
    Porcellini A; Ciullo I; Pannain S; Fenzi G; Avvedimento E
    Oncogene; 1995 Sep; 11(6):1089-93. PubMed ID: 7566968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor.
    Lalli E; Sassone-Corsi P
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9633-7. PubMed ID: 7568187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential role of CREB phosphorylation in cAMP-inducible gene expression in the rat pineal.
    Spessert R; Rapp M; Jastrow H; Karabul N; Blum F; Vollrath L
    Brain Res; 2000 May; 864(2):270-80. PubMed ID: 10802034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas.
    Persani L; Lania A; Alberti L; Romoli R; Mantovani G; Filetti S; Spada A; Conti M
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2872-8. PubMed ID: 10946896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
    Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of type II iodothyronine deiodinase in human thyroid gland.
    Murakami M; Araki O; Hosoi Y; Kamiya Y; Morimura T; Ogiwara T; Mizuma H; Mori M
    Endocrinology; 2001 Jul; 142(7):2961-7. PubMed ID: 11416017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coupling gene expression to cAMP signalling: role of CREB and CREM.
    Sassone-Corsi P
    Int J Biochem Cell Biol; 1998 Jan; 30(1):27-38. PubMed ID: 9597751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
    Nogueira CR; Kopp P; Arseven OK; Santos CL; Jameson JL; Medeiros-Neto G
    Thyroid; 1999 Nov; 9(11):1063-8. PubMed ID: 10595453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.